Clinical Trial Update: Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study comparing NXL103 to Linezolid for acute bacterial skin and skin structure infections in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Linezolid (Linezolid)
• NXL103

Snippet

Sponsor: Novexel Inc | Conditions: Acute Bacterial Skin and Skin Structure Infections | Phase 2 | Status: COMPLETED